期刊文献+

急性心肌梗死和冠脉支架术后再狭窄患者氯吡格雷抵抗相关因素分析 被引量:10

Predictive factors of clopidogrel resistance in patients with acute myocardial infarction or coronary artery in-stent restenosis
下载PDF
导出
摘要 目的探讨急性心肌梗死和冠脉支架内再狭窄患者双联抗血小板治疗后氯吡格雷抵抗的发生率及相关影响因素。方法对102例急性心肌梗死和冠脉支架内再狭窄的患者给予氯吡格雷治疗后,经Verify Now检测系统测定血小板功能。以Verify Now测试结果 P2Y12反应单位≥208定义为氯吡格雷抵抗。比较氯吡格雷抵抗患者和无氯吡格雷抵抗患者的一般临床资料、基因多态性、实验室指标和影像学特征差异,分析氯吡格雷抵抗的相关因素。结果氯吡格雷抵抗发生率为47.06%,两组在女性、年龄、全球急性冠状动脉事件注册危险(GRACE)评分、尿素氮、血红蛋白、红细胞计数、肌酸激酶同工酶(CKMB)、CYP2C19*2基因型的差异有统计学意义(P〈0.05)。相关性分析显示,氯吡格雷抵抗与年龄、性别、尿素氮、肾小球滤过率、红细胞计数、血红蛋白、GRACE评分、GRUSADE评分、CYP2C19*2纯合子基因型存在相关性(P〈0.05),相关系数在0.2~0.5间。Logistic回归结果发现GRACE评分、CYP2C19*2基因型、尿素氮可能是氯吡格雷抵抗的独立预测因素(P〈0.05)。结论 GRACE评分、CYP2C19*2纯合子基因型、尿素氮可能是氯吡格雷抵抗的独立预测因素。 Objective To investigate the incidence and influential factors of clopidogrel resistance in patients with acute myocardial infarction(AMI) or coronary artery in-stem restenosis (ISR). Methods A total of 102 cases of patients with AMI or ISR were en- rolled, after receiving clopidogrel therapy, platelet function was evaluated by VerifyNow testing. P2Y12 reaction units(PRU) ≥208 were defined as clopidogrel resistance. The patients were divided into the clopidogrel-resistant group and clopidogre non-resistance group. The Baseline characteristics, gene polymorphism,laboratory and angiographic characteristics were compared between two groups. Inde- pendent predictive factors of clopidogrel resistance were explored by multiple factor analysis. Results The incidence of clopidogrel re- sistance in 102 cases of patients was 47.06%. Baseline characteristics, gene polymorphism,laboratory and angiographic characteristics were similar in clopidogrel resistance( n = 48 )and clopidogrel non-resistance group (n = 54). There were significant differences be- tween treatment groups with regards to gender, age, urea nitrogen, hemoglobin, CK-MB, GRACE score and CYP2C19 * 2 genotype ( P 〈 0. 05). There were correlation between clopidogrel resistance and factors as age, gender, urea nitrogen, glomerular filtration rate, red blood cell count, hemoglobin, GRACE score, GRUSADE score and CYP2C19 * 2 homozygote genotype. The correlation coefficient was 0.2 - 0. 5. In the further logistic regression analysis, CYP2C19 * 2 homozygote genotype, GRACE score, urea nitrogen were found to be possibly predictors of clopidogrel resistance (P 〈 0. 05 ). Conclusion CYP2C19 * 2 homozygote genotype, GRACE score and Urea ni- trogen may be independent predictors of clopidogrel resistance in patients with AMI or ISR.
出处 《临床军医杂志》 CAS 2016年第5期470-476,共7页 Clinical Journal of Medical Officers
基金 上海市科委基金(134119a0301)
关键词 氯吡格雷抵抗 血小板功能检测 Verify Now系统 预测因素 Clopidogrel resistant VerifyNow Platelet function testing Predictive factors
  • 相关文献

参考文献29

  • 1Patrono C,Andreotti F,Arnesen H,et al.Antiplatelet agents for the treatment and prevention of atherothrombosis[J].Eur Heart J,2011,32(23):2922-2932. 被引量:1
  • 2Steinhub SR,Berger PB,Mann JT,et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial[J].JAMA,2002,288(19):2411-2420. 被引量:1
  • 3Van de Werf F,Bax J,Betriu A,et al.Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation:the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology[J].Eur Heart J,2008,29(23):2909-2945. 被引量:1
  • 4Vlachojannis GJ,Dimitropoulos G,Alexopoulos D.Clopidogrel resistance:current aspects and future directions[J].Hellenic J Cardiol,2011,52(3):236-245. 被引量:1
  • 5Matetzky S,Shenkman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction[J].Circulation,2004,109(25):3171-3175. 被引量:1
  • 6Frere C,Cuisset T,Morange PE.Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome[J].Am J Cardiol,2008,101(8):1088-1093. 被引量:1
  • 7Stone GW,Witzenbichler B,Weisz G,et al.Platelet reactivity and clinical outcomes aftr coronary artery implantation of drug-eluting stents(ADAPTDES):a prospective multicentre registry study[J].Lancet,2013,382(9892):614-623. 被引量:1
  • 8Gorog DA,Fuster V.Platelet function tests in clinical cardiology:unfulfilled expectations[J].J Am Coll Cardiol,2013,61(21):2115-2129. 被引量:1
  • 9Gremmel T,Steiner S,Seidinger D,et al.Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation[J].Thomb Haemost,2009,101(2):333-339. 被引量:1
  • 10Ben-Dor I,Kleiman NS,Lev E.Assessment,mechanisms,and clinical implication of variability in platelet response to aspirin and clopidogrel therapy[J].Am J Cardiol,2009,104(2):227-233. 被引量:1

二级参考文献60

  • 1Gurbel PA, Becker RC, Mann KG, et al. Platelet function mo- nitoring in patients with coronary artery disease. J Am Coil Cardiol, 2007,50 : 1822-1834. 被引量:1
  • 2Breet NJ,van Werkum JW, Bouman H J, et al. Comparison of platelet function tests in predicting clinical outcome in pa- tients undergoing coronary stent implantation. JAMA, 2010, 303:754-762. 被引量:1
  • 3Price MJ,Angiolillo DJ,Teirstein PS, et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary in- tervention:a time-dependent analysis of the gauging respon- siveness with a VerifyNow P2Y12 assay:impact on thrombosis and safety (gravitas) trial. Circulation,2011,124 : 1132-1137. 被引量:1
  • 4Campo G, Parrinello G, Ferraresi P, et al. Prospective evalua- tion of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol, 2011,57 : 247-2483. 被引量:1
  • 5Silvain J, Cayla G, Hulot JS, et al. High on thienopyridine platelet reactivity in elderly coronary patients the senior- platelet study. Eur Heart J, 2012,33 : 1241 -1249. 被引量:1
  • 6Ang L,Palakodeti V,Khalid A,et al. Elevated plasma fibrino- gen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. J Am Coil Cardiol, 2008,52 : 1052-1059. 被引量:1
  • 7Morel O,E1 Ghannudi S,Jesel L,et al. Cardiovascular mortal ity in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Yz in- hibition by clopidogrel. J Am Coll Cardiol, 2011,57 : 399-408. 被引量:1
  • 8Leng WX,Ren JW,Cao J, et al. Chronic kidney disease-is it a true risk factor of reduced clopidogrel efficacy in elderly pa- tients with stable coronary artery disease? Thromb Res, 2013,131 : 218-224. 被引量:1
  • 9Linden MD, Tran H, Woods R, et al. High platelet reactivity and antiplatelet therapy resistance. Semin Thromb Hemost, 2012,38:200-212. 被引量:1
  • 10Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspi rin: the randomized, double blind OCLA (omeprazole clopi- dogrel aspirin) study. J Am Coil Cardiol, 2008,51 : 256-260. 被引量:1

共引文献42

同被引文献99

引证文献10

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部